Page 25 - ITPS-5-2
P. 25

19    INNOSC Theranostics and Pharmacological Sciences, 2022, Vol. 5, No. 2          Govender and Hodkinson

            Table 4. Positive anti-neutrophil cytoplasmic antibody results in patients with no evidence of
            anti-neutrophil cytoplasmic antibody-associated vasculitis

            Gender    Age   Ethnicity  MPO     PR3    Guideline   Indication description  Clinical information
                                                      indication
            M         47    African    Pos     Neg    Yes         GN                    HIV, AKI due to hypertension
                                                                                        nephrosclerosis
            F         48    African    Pos     Neg    Yes         GN                    HIV, HIVAN
            F         43    African    Pos     Neg    No          Hepatitis             HIV, confirmed DILI
            F         33    Mixed      Neg     Pos    No          Hepatomegaly and      HIV, HIV seroconversion
                                                                  lymphadenopathy
            M         47    Mixed      Neg     Pos    No          Cholangitis           HIV, syphilis, confirmed liver
                                                                                        abscesses
            F         44    African    Pos     Pos    Yes         Palpable purpura      HIV, biopsy- cutaneous lupus
            M         35    African    Neg     Pos    Yes         GN                    TB, AKI, and macroscopic
                                                                                        haematuria
            F         38    African    Pos     neg    No          AKI                   HIV, disseminated TB
            F         30    African    Pos     Neg    Yes         PN                    HIV, TB
            M         39    African    Pos     Neg    No          Valve heart disease   HIV, TB, epilepsy
            F         57    Mixed      Neg     Pos    No          Seizures              HPT, syphilis
            F         80    Mixed      Pos     Neg    No          ILD                   RA, HPT, hyperthyroidism
            M         38    Caucasian  Pos     Neg    No          Hepatitis             AIH
            F         55    African    Pos     Neg    No          Unclear               SLE
            M         67    Mixed      Pos     Neg    Yes         GN                    HPT, biopsy- diffuse
                                                                                        glomerulosclerosis
            F         69    Mixed      Pos     Neg    Yes         GN                    HPT, DM, asthma, biopsy-
                                                                                        MCGN, and ATN
            M         47    African    Pos     Neg    No          AKI                   -
            F         62    Mixed      Pos     Neg    Yes         PN                    HPT, ILD
            F         68    Mixed      Pos     Neg    No          Myelopathy            HPT
            F         73    Mixed      Pos     Neg    No          ILD                   HPT, DM
            F         54    Mixed      Pos     Neg    No          Poorly controlled     HPT, asthma
                                                                  asthma
            M         29    African    Pos     Pos    No          Uveitis               -
            M         66    Mixed      Neg     Pos    Yes         Scleritis             HPT
            M         41    Asian      Neg     Pos    No          Amblyopia             -
            F         48    Mixed      Neg     Pos    No          Raynaud’s             Breast cancer in remission
                                                                  phenomenon
            F         38    African    Pos     Neg    No          POF                   -
            Abbreviations; AIH: Autoimmune hepatitis. AKI: Acute kidney injury, ATN: Acute tubular necrosis, DILI: Drug-induced liver injury,
            DM: Diabetes mellitus, F: Female, GN: Glomerulonephritis, HIV: Human immunodeficiency virus, HIVAN: HIV associated nephropathy,
            HPT: Hypertension, ILD: Interstitial lung disease, LN: Lupus nephritis, M: Male, MCGN: Mesangiocapillary glomerulonephritis,
            MPO: Anti-myeloperoxidase antibodies, Neg: Negative, PN: Peripheral neuropathy, POF: Premature ovarian failure, Pos: Positive,
            PR3: Anti-proteinase 3 antibodies, RA: Rheumatoid arthritis, SLE: Systemic lupus erythematosus, TB: Tuberculosis.

           test plays an important  role as a screening tool.   and lowers the test sensitivity and PPV. Similar
           However, our study revealed that only a quarter of   studies conducted  elsewhere  reported  that  33.4%
           ANCA tests conducted had indications that met the    and 50.0% of ANCA tests were performed within
           1999 international consensus statement guidelines.   guideline indications [9,10]. Implementing gating
           This indiscriminate use of ANCA testing is costly    policies  to restrict  ANCA testing  has proven

                                                    ©2022 AccScience Publishing
   20   21   22   23   24   25   26   27   28   29   30